Michael Banks, MD, on Hepatocellular Carcinoma Risk Persists in Patients With HCV-Related Cirrhosis

Michael Banks, MD, discusses the risk for cirrhosis regression and liver cancer in patients with HCV-related cirrhosis who have already achieved sustained virologic response via direct-acting antiviral treatment.

Additional Resources:

The Doctor's Channel.

Submit Feedback

Name